News
A recent study published in the British Medical Journal has shown that even when patients know they're taking a placebo, the ...
10h
Medpage Today on MSNAntiviral Reduced Transmission of Influenza to Close ContactsA single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to ...
Microdosing might not work the way we think—but that doesn’t mean it doesn’t work. Here’s what science and the placebo effect ...
Bristol Myers' schizophrenia drug Cobenfy stumbles as adjunctive treatment, denting blockbuster plan
Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...
The use of lemborexant vs placebo is effective and well-tolerated to treat sleep symptoms among patients with insomnia.
A new medication called zilebesiran may offer fresh hope for people with high blood pressure, according to a recent study ...
10h
Medpage Today on MSNNovel DPP-1 Drug Trims Exacerbation Risk in BronchiectasisThe ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% ...
Rilzabrutinib significantly reduces itch and hives in patients with chronic spontaneous urticaria unresponsive to ...
Our data confirm that, although significant placebo and nocebo effects were found on days 1 and 8, the nocebo effect was consistently stronger. Both effects were primarily influenced by the most ...
Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results